Published in J Immunol on March 01, 1978
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells. J Exp Med (1979) 2.40
Immune suppression in vivo with antigen-modified syngeneic cells. I. T-cell-mediated suppression to the terpolymer poly-(Glu, Lys, Phe)n. J Exp Med (1978) 1.03
Nucleic acid-specific suppressor T cells. Proc Natl Acad Sci U S A (1980) 0.81
Induction of tolerance by haptenated liposomes carrying mouse erythrocyte membrane glycoprotein. Immunology (1984) 0.75
Cell selection by antigen in the immune response. Adv Immunol (1969) 6.05
Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. J Exp Med (1976) 4.63
Lymphocyte transformation induced by autologous cells. V. Generation of immunologic memory and specificity during the autologous mixed lymphocyte reaction. J Exp Med (1977) 3.06
Secondary antibody responses in haptenic systems: cell population selection by antigen. J Immunol (1967) 3.01
Autologous mixed lymphocyte culture reactions and generation of cytotoxic T cells. J Exp Med (1977) 2.66
Fire and flood management of coastal swamp enabled first rice paddy cultivation in east China. Nature (2007) 2.36
Impaired lymphocyte function in aged humans. J Clin Invest (1974) 2.32
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27
Distribution of antibody affinities: technique of measurement. Immunochemistry (1972) 2.24
Studies on the induction of immunological unresponsiveness to pneumococcal polysaccharide in mice. J Exp Med (1966) 2.24
Studies on the control of antibody synthesis. Effect of antibody affinity upon its ability to suppress antibody formation. Immunology (1968) 2.20
Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med (1976) 2.18
Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized. J Exp Med (1966) 2.16
Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology (1973) 2.07
Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest (1981) 2.04
Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies. J Exp Med (1966) 1.94
Studies on the control of antibody synthesis. II. Effect of antigen dose and of suppression by passive antibody on the affinity of antibody synthesized. J Exp Med (1968) 1.89
Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J Exp Med (1967) 1.89
Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice. J Exp Med (1974) 1.86
Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol (1997) 1.84
Selection of cell populations in induction of tolerance: affinity of antibody formed in partially tolerant rabbits. J Immunol (1968) 1.82
A study of the 'termination' of tolerance to BSA with DNP-BSA in rabbits: relative affinities of the antibodies for the immunizing and the paralysing antigens. Immunology (1967) 1.82
New goals for education in geriatric medicine. Ann Intern Med (1983) 1.80
The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest (1979) 1.67
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
The effect of antigen dose and time after immunization on the amount and affinity of anti-hapten antibody. J Immunol (1968) 1.61
The autologous mixed-lymphocyte reaction. Adv Immunol (1981) 1.59
Immunological studies of Aging. III. Cytokinetic basis for the impaired response of lymphocytes from aged humans to plant lectins. J Exp Med (1977) 1.56
Induction of suppressor activity in the autologous mixed lymphocyte reaction and in cultures with concanavalin A. J Clin Invest (1979) 1.52
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1. J Immunol (1985) 1.39
Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1972) 1.39
Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas. J Exp Med (1984) 1.37
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine (1989) 1.35
Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev (1997) 1.32
Lymphocyte transformation induced by autologous cells. XII. Quantitative and qualitative differences between human autologous and allogeneic reactive T lymphocytes. J Immunol (1982) 1.30
Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J Immunol (2000) 1.29
Synergy between human T and B lymphocytes in their response to phythaemagglutinin and pokeweed mitogen. Immunology (1976) 1.27
Studies on antigenic competition. J Exp Med (1969) 1.26
Effect of tolerance and immunity on antibody affinity. Transplant Rev (1972) 1.25
Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol (1995) 1.25
The effect of dose in tolerance induction on the subsequent response to a cross-reactive antigen. Immunology (1969) 1.23
Studies on the control of antibody synthesis. VI. Effect of antigen dose and time after immunization on antibody affinity and heterogeneity in the mouse. Clin Exp Immunol (1974) 1.22
Studies on immunological paralysis. I. A consideration of macrophage involvement in the induction of paralysis and immunity by type II pneumococcal polysaccharide. Clin Exp Immunol (1969) 1.22
Lymphocyte transformation induced by autologous cells. VIII. Impaired autologous mixed lymphocyte reactivity in patients with acute infectious mononucleosis. J Exp Med (1979) 1.21
Immunologic studies of aging. V. Impaired proliferation of PHA responsive human lymphocytes in culture. J Immunol (1980) 1.21
Ontogeny of B-lymphocyte function. II. Ability of endotoxin to increase the heterogeneity of affinity of the immune response of B lymphocytes from fetal mice. J Exp Med (1976) 1.18
Autologous and allogeneic stimulation of peripheral human leukocytes. Cell Immunol (1972) 1.18
Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines. J Clin Invest (1972) 1.15
Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol (1992) 1.11
Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood (2000) 1.10
Lymphocyte transformation induced by autologous cells. III. Lymphoblast-induced lymphocyte to stimulation does not correlate with EB viral antigen expression or immunity. J Immunol (1976) 1.10
Electron transfer in photosystem II at cryogenic temperatures. Biochemistry (1985) 1.10
Studies on the control of antibody synthesis. XII. Genetic influences on antibody affinity. Immunology (1978) 1.10
The role of circulating antibody in the control of antibody synthesis: mechanism for the suppressive effect of passive antibody on active antibody synthesis. Transfusion (1968) 1.10
Immunization of elderly people with high doses of influenza vaccine. J Am Geriatr Soc (1988) 1.09
Host defense mechanisms and aging. Semin Oncol (1989) 1.09
Production of auto-anti-idiotypic antibody during the normal immune response: changes in the auto-anti-idiotypic antibody response and the idiotype repertoire associated with aging. Proc Natl Acad Sci U S A (1980) 1.09
Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice. J Exp Med (1977) 1.06
Aging and arteriosclerosis. Cell cycle kinetics of young and old arterial smooth muscle cells. Am J Pathol (1988) 1.06
T cells with receptors for IgD. Nature (1985) 1.05
Aging and arteriosclerosis. I. Development of myointimal hyperplasia after endothelial injury. J Exp Med (1986) 1.05
Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. III. Absence in nu/nu mice: evidence for T-cell dependence of the anti-idiotypic-antibody response. J Exp Med (1979) 1.05
Studies on the control of antibody synthesis. V. Effect of nonspecific modification of the magnitude of the immune response on the affinity of the antibody synthesized. J Immunol (1974) 1.03
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med (1972) 1.03
Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations. J Exp Med (1985) 1.01
Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates. J Exp Med (1973) 1.00
A comparison of the Farr technique with equilibrium dialysis for measurement of antibody concentration and affinity. J Immunol Methods (1975) 0.99
Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol (1988) 0.99
Determination of antibody avidity at the cellular level by the plaque inhibition technique: effect of valence of the inhibitor. J Immunol Methods (1975) 0.97
Effect of variation in antibody-hapten association constant upon the biologic activity of the antibody. J Immunol (1965) 0.97
An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann Neurol (1985) 0.97
Ontogeny of B-lymphocyte function. V. Thymus cell involvement in the functional maturation of B-lymphocytes from fetal mice transferred into adult irradiated hosts. J Exp Med (1978) 0.97
Immunization of elderly people with two doses of influenza vaccine. J Clin Microbiol (1987) 0.96
Cellular control of IgE induction by a polyphenol-rich compound. Preferential activation of Th2 cells. J Immunol (1990) 0.96
The anamnestic antibody response to type 3 specific pneumococcal polysaccharide. J Exp Med (1969) 0.96
Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies. J Exp Med (1981) 0.96
Host resistance and the immune system. Clin Geriatr Med (1992) 0.96
Age related changes in the in vitro immune response: increased suppressor activity in immature and aged mice. J Immunol (1980) 0.95
Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol (1972) 0.95
Changes in affinity of 19 and 7S antibodies at the cellular level in responses to hapten conjugates of varying T dependency. Cell Immunol (1978) 0.95
Lymphocyte transformation induced by autologous cells: XVIII. Impaired autologous mixed lymphocyte reaction in subjects with AIDS-related complex. Clin Exp Immunol (1987) 0.95
Clonal expansions of B lymphocytes in old mice. J Immunol (1997) 0.95